185 related articles for article (PubMed ID: 25257978)
41. Exercise and Counseling for Smoking Cessation in Smokers With Depressive Symptoms: A Randomized Controlled Pilot Trial.
Bernard P; Ninot G; Cyprien F; Courtet P; Guillaume S; Georgescu V; Picot MC; Taylor A; Quantin X
J Dual Diagn; 2015; 11(3-4):205-16. PubMed ID: 26683252
[TBL] [Abstract][Full Text] [Related]
42. Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment.
Schnoll RA; Martinez E; Tatum KL; Glass M; Bernath A; Ferris D; Reynolds P
Addict Behav; 2011; 36(1-2):144-7. PubMed ID: 20869812
[TBL] [Abstract][Full Text] [Related]
43. Relapse Rate and Factors Related to Relapse in a 1-Year Follow-Up of Subjects Participating in a Smoking Cessation Program.
Koçak ND; Eren A; Boğa S; Aktürk ÜA; Öztürk ÜA; Arınç S; Şengül A
Respir Care; 2015 Dec; 60(12):1796-803. PubMed ID: 26286738
[TBL] [Abstract][Full Text] [Related]
44. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
[TBL] [Abstract][Full Text] [Related]
45. Relationship of perceived risks of smoking cessation to symptoms of withdrawal, craving, and depression during short-term smoking abstinence.
Weinberger AH; Krishnan-Sarin S; Mazure CM; McKee SA
Addict Behav; 2008 Jul; 33(7):960-3. PubMed ID: 18384974
[TBL] [Abstract][Full Text] [Related]
46. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J
Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727
[TBL] [Abstract][Full Text] [Related]
47. The effect of bupropion on nicotine craving and withdrawal.
Shiffman S; Johnston JA; Khayrallah M; Elash CA; Gwaltney CJ; Paty JA; Gnys M; Evoniuk G; DeVeaugh-Geiss J
Psychopharmacology (Berl); 2000 Jan; 148(1):33-40. PubMed ID: 10663415
[TBL] [Abstract][Full Text] [Related]
48. Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation.
Schnoll RA; Epstein L; Audrain J; Niaura R; Hawk L; Shields PG; Lerman C; Wileyto EP
J Subst Abuse Treat; 2008 Mar; 34(2):234-41. PubMed ID: 17600649
[TBL] [Abstract][Full Text] [Related]
49. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.
Collins BN; Wileyto EP; Patterson F; Rukstalis M; Audrain-McGovern J; Kaufmann V; Pinto A; Hawk L; Niaura R; Epstein LH; Lerman C
Nicotine Tob Res; 2004 Feb; 6(1):27-37. PubMed ID: 14982685
[TBL] [Abstract][Full Text] [Related]
50. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
[TBL] [Abstract][Full Text] [Related]
51. Evaluating the effect of smoking cessation treatment on a complex dynamical system.
Bekiroglu K; Russell MA; Lagoa CM; Lanza ST; Piper ME
Drug Alcohol Depend; 2017 Nov; 180():215-222. PubMed ID: 28922651
[TBL] [Abstract][Full Text] [Related]
52. Predicting smoking cessation. Who will quit with and without the nicotine patch.
Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
[TBL] [Abstract][Full Text] [Related]
53. A randomized trial of nortriptyline for smoking cessation.
Prochazka AV; Weaver MJ; Keller RT; Fryer GE; Licari PA; Lofaso D
Arch Intern Med; 1998 Oct; 158(18):2035-9. PubMed ID: 9778204
[TBL] [Abstract][Full Text] [Related]
54. Withdrawal exposure with withdrawal regulation training for smoking cessation: a randomized controlled pilot trial.
Hendricks PS; Hall SM; Tyus LR; Thorne CB; Lappan SN; McMurray MV; Bailey WC; Cropsey KL; Baker TB
Drug Alcohol Depend; 2016 Jul; 164():28-37. PubMed ID: 27179823
[TBL] [Abstract][Full Text] [Related]
55. Depression motivates quit attempts but predicts relapse: differential findings for gender from the International Tobacco Control Study.
Cooper J; Borland R; McKee SA; Yong HH; Dugué PA
Addiction; 2016 Aug; 111(8):1438-47. PubMed ID: 26888199
[TBL] [Abstract][Full Text] [Related]
56. Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment.
Strong DR; Kahler CW; Leventhal AM; Abrantes AM; Lloyd-Richardson E; Niaura R; Brown RA
Nicotine Tob Res; 2009 Oct; 11(10):1142-53. PubMed ID: 19574407
[TBL] [Abstract][Full Text] [Related]
57. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB
Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757
[TBL] [Abstract][Full Text] [Related]
58. Anxiety Sensitivity and Distress Tolerance in Smokers: Relations With Tobacco Dependence, Withdrawal, and Quitting Success†.
Schlam TR; Baker TB; Smith SS; Cook JW; Piper ME
Nicotine Tob Res; 2020 Jan; 22(1):58-65. PubMed ID: 31056710
[TBL] [Abstract][Full Text] [Related]
59. A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol-Dependent Men.
Anthenelli RM; Heffner JL; Wong E; Tibbs J; Russell K; Isgro M; Dinh E; Wehrle C; Worley MJ; Doran N
Alcohol Clin Exp Res; 2017 Jan; 41(1):197-206. PubMed ID: 28029173
[TBL] [Abstract][Full Text] [Related]
60. Time-varying smoking abstinence predicts lower depressive symptoms following smoking cessation treatment.
Kahler CW; Spillane NS; Busch AM; Leventhal AM
Nicotine Tob Res; 2011 Feb; 13(2):146-50. PubMed ID: 21106663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
